|
2004
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
December 2004
November 2004
- First
Monoclonal Antibody Treatment For Multiple Sclerosis Approved (November 23, 2004)
- FDA Acts to
Remove Ephedra-Containing Dietary Supplements From Market (November 23, 2004)
- FDA Approves
New Drug for the Most Common Type of Lung Cancer (November
19)
- Statement
by Dr. Steven Galson, Acting Director, Center for Drug Evaluation
and Research (CDER), Regarding November 18, 2004, Committee
on Finance of the U.S. Senate Hearing on Drug Safety and the
Worldwide Withdrawal by Merck & Co., Inc., of Vioxx (November 18)
- FDA Improves
the Safety of Human Cells and Tissues by Finalizing New Rules
for "Good Tissue Practice" (November 18)
- FDA Statement
on Vioxx and Recent Allegations and the Agency’s Continued
Commitment to Sound Science and Peer Review (November
17)
- Statement
of Dr. Lester M. Crawford, Acting Commissioner of Food and
Drugs on the Resignation of Daniel E. Troy (November
16)
- FDA To Announce
Important Labeling Changes for Mifepristone (November
15)
- FDA Announces
New Initiative to Protect the U.S. Drug Supply Through the
Use Of Radiofrequency Identification Technology (November
15)
- Sentence Ordered
in Drug Counterfeiting Case (November 9)
- FDA Acts to
Strengthen the Safety Program for Marketed Drugs (November
5)
- FDA Announces
Major Initiatives for Dietary Supplements (November
4)
- FDA Allows
Qualified Health Claim to Decrease Risk of Coronary Heart
Disease (November 1)
October 2004
September 2004
August 2004
July 2004
- FDA Analyses Finds Ground Castor Beans - Not Purified Ricin -- in Two Tampered Baby Food Jars In Irvine, California Case (July 28, 2004)
- FDA Issues Alert on Foodborne Illness Outbreaks in Pennsylvania and Mid-Atlantic States (July 23, 2004)
- Metabolife,
Founder Indicted for Lying to FDA about Ephedra Risks (DOJ,
July 22)
- FDA Announces Standard Format That Drug Sponsors Can
Use to Submit Human Drug Clinical Trial Data (July 21)
- FDA Commends
Passage by the House of Representatives of S. 741, a Bill
Providing Improved Consumer Protection and Incentives for
Animal Drug Development (July 20)
- Schultz
Named Director of FDA's Devices Center (July 20)
- FDA Proposes
Changes To Provide Clearer Information To Drug Sponsors Concerning
Reviews of Their New Drug Applications (July 19)
- FDA to Establish
New Cancer Office and Program (July 16)
- FDA Issues
Alert on Foodborne Illness Outbreaks in Pennsylvania And Mid-Atlantic
States (July 16)
- Acting FDA
Commissioner Dr. Lester M. Crawford Names Michael M. Landa,
Esq., Deputy Director of FDA's Center for Food Safety and
Applied Nutrition (July 15)
- FDA Approves
New Use of Drug to Treat Superficial Basal Cell Carcinoma,
a Type of Skin Cancer (July 15)
- FDA Test Results
of Prescription Drugs from Bogus Canadian Website Show All
Products Are Fake and Substandard (July 13)
- U.S. District
Judge Issues Permanent Injunction Against Lane Labs-USA, Inc.
and Orders Firm to Refund Money to Purchasers of Illegally
Marketed Unapproved Drugs (July 13)
- Statement
by Dr. Lester M. Crawford, Acting FDA Commissioner in Response
to A Release Issued Today by Rep. Maurice Hinchey (July 13)
- USDA and HHS
Strengthen Safeguards against Bovine Spongiform Encephalopathy (July 9)
June 2004
May 2004
April 2004
March 2004
- FDA Moves
Forward on Qualified Health Claims (March 31)
- Aloe Commodities
International, Inc., Recalls Solutions IE Ageless Formula
II Due to Excess Vitamin D (March 26)
- NIH
and FDA Launch New Human Gene Transfer Research Data System (NIH/FDA release, March 26)
- FDA Approves
First Oral Fluid Based Rapid HIV Test Kit (March 26)
- FDA Enhances
Safeguards For Consumers Who May Have Special Sensitivities
to Certain Commonly Used Over-the-Counter Drug Ingredients (March 25)
- FDA Releases
Acrylamide Data and Final Acrylamide Action Plan (March
25)
- Statement
on Generic Oxycodone Hydrochloride Extended Release Tablets (March 23)
- FDA and EPA
Announce the Revised Consumer Advisory on Methylmercury in
Fish (March 19)
- Dietary Supplement
Firms, Seasilver USA, Inc. and Americaloe, Inc., Sign Consent
Decree (March 17)
- FDA and the
U.S. Attorney for the Western District of Texas Announce Guilty
Plea in Drug Counterfeiting Case (March 17)
- Report Seeks
to Improve "Critical Path" of Medical Product Development (March 16)
- HHS Unveils
FDA Strategy to Help Reduce Obesity (HHS Release,
March 12)
- Statement
by Tommy G. Thompson Secretary of Health and Human Services
Regarding Confirmation of Mark B. McClellan to Lead CMS (HHS Release, March 12)
- HHS Launches
Crackdown on Products Containing Andro (HHS release,
March 11)
- FDA Commends
Senate Passage of Bill Providing Improved Consumer Protection
and Incentives for Animal Drug Development (March
9)
- FDA Issues
Recommendations on Development of Drugs to Treat Side Effects
of Vaccination Against Smallpox (March 8)
- FDA Announces
Nationwide Recall of Faulty Patients Lifts (March
4)
- FDA Launches
New Easy-to-Use Drug Information Web Site (March 3)
- FDA Announces
Measures to Improve Generic Drug Access (March 2)
- U.S.
Drug Prevention, Treatment, Enforcement Agencies Take on "Doctor
Shoppers," "Pill Mills" (White House
Release, March 1)
February 2004
January 2004
|
|
|
|
|
|
|